Subtopic Deep Dive
Global Tuberculosis Epidemiology
Research Guide
What is Global Tuberculosis Epidemiology?
Global Tuberculosis Epidemiology analyzes worldwide incidence, prevalence, transmission dynamics, and risk factors of Mycobacterium tuberculosis using surveillance data and mathematical modeling.
This subtopic relies on WHO surveillance and modeling to track TB burden, with foundational estimates like 7.96 million new cases in 1997 (Dye et al., 1999, 2960 citations). Latent TB infection affects 1.7 billion people globally as re-estimated in 2014 (Houben and Dodd, 2016, 1969 citations). Key risks include HIV coinfection (Selwyn et al., 1989, 1579 citations) and diabetes (Jeon and Murray, 2008, 1479 citations).
Why It Matters
Epidemiological data from Dye et al. (1999) guide WHO's End TB Strategy by identifying high-burden regions for targeted interventions. HIV-TB risk modeling by Selwyn et al. (1989) informs screening in drug users, reducing reactivation rates. Diabetes-TB links from Jeon and Murray (2008) support integrated screening programs in high-prevalence areas like India and China, preventing millions of cases annually.
Key Research Challenges
Underreporting in Low-Resource Areas
Surveillance gaps in high-burden countries lead to underestimated incidence, as seen in Dye et al. (1999) range of 6.3-11.1 million cases. Modeling must account for diagnostic access disparities. Improved notification systems are needed (Houben and Dodd, 2016).
Quantifying Latent TB Burden
Estimating 1.7 billion latent infections requires mathematical models sensitive to reactivation risks (Houben and Dodd, 2016). HIV and diabetes comorbidities complicate prevalence calculations (Selwyn et al., 1989; Jeon and Murray, 2008). Validation against cohort data remains inconsistent.
Modeling Transmission Dynamics
HIV-TB coinfection dynamics challenge standard models, with elevated risks in vulnerable groups (Selwyn et al., 1989). Social determinants like drug use require network-based simulations. Integration with genomic data is emerging but data-limited.
Essential Papers
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng, Hai Yun Shi, Nurkholis Hamidi et al. · 2017 · The Lancet · 5.6K citations
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky, Ing Shian Soon, Doreen M. Rabi et al. · 2011 · Gastroenterology · 4.7K citations
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · 2001 · New England Journal of Medicine · 3.7K citations
Active tuberculosis may develop soon after the initiation of treatment with infliximab. Before prescribing the drug, physicians should screen patients for latent tuberculosis infection or disease.
Global Burden of Tuberculosis
Christopher Dye, S Scheele, Paul Dolin et al. · 1999 · JAMA · 3.0K citations
In 1997, new cases of TB totaled an estimated 7.96 million (range, 6.3 million-11.1 million), including 3.52 million (2.8 million-4.9 million) cases (44%) of infectious pulmonary disease (smear-pos...
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · 2004 · Science · 2.1K citations
The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years. We identified a diary...
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Rein M G J Houben, Peter J. Dodd · 2016 · PLoS Medicine · 2.0K citations
We estimate that approximately 1.7 billion individuals were latently infected with Mycobacterium tuberculosis (M.tb) globally in 2014, just under a quarter of the global population. Investment in n...
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Jerry A. Winkelstein, Mary C. Marino, Richard B. Johnston et al. · 2000 · Medicine · 1.7K citations
A registry of United States residents with chronic granulomatous disease (CGD) was established in 1993 in order to estimate the minimum incidence of this uncommon primary immunodeficiency disease a...
Reading Guide
Foundational Papers
Start with Dye et al. (1999) for baseline global burden estimates (2960 citations); then Selwyn et al. (1989) for HIV-TB dynamics foundational to coinfection studies.
Recent Advances
Houben and Dodd (2016) updates latent TB to 1.7 billion cases; Jeon and Murray (2008) quantifies diabetes risk across 13 studies.
Core Methods
Surveillance modeling (Dye et al., 1999), mathematical re-estimation (Houben and Dodd, 2016), prospective cohort analysis (Selwyn et al., 1989), systematic reviews (Jeon and Murray, 2008).
How PapersFlow Helps You Research Global Tuberculosis Epidemiology
Discover & Search
Research Agent uses searchPapers and exaSearch to query 'global TB incidence trends WHO data' yielding Dye et al. (1999); citationGraph reveals connections to Houben and Dodd (2016); findSimilarPapers surfaces Jeon and Murray (2008) for risk factors.
Analyze & Verify
Analysis Agent applies readPaperContent to extract incidence ranges from Dye et al. (1999), then runPythonAnalysis with pandas to plot trends across papers; verifyResponse via CoVe checks model assumptions against Selwyn et al. (1989); GRADE grading scores evidence quality for HIV-TB risks.
Synthesize & Write
Synthesis Agent detects gaps in latent TB modeling post-Houben and Dodd (2016); Writing Agent uses latexEditText and latexSyncCitations to draft review sections citing Dye et al. (1999), with latexCompile for PDF output and exportMermaid for transmission flowcharts.
Use Cases
"Analyze TB incidence trends from 1990-2020 using Python visualization"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot of Dye et al. 1999 and Houben 2016 data) → matplotlib incidence graph exported as PNG.
"Write LaTeX systematic review on HIV-TB coinfection risks"
Research Agent → citationGraph (Selwyn 1989 cluster) → Synthesis → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → camera-ready PDF with 20+ citations.
"Find code for TB transmission models from recent papers"
Research Agent → findSimilarPapers (Houben 2016) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python simulation scripts for latent TB dynamics.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ TB epi papers) → citationGraph → DeepScan (7-step verification with CoVe on Dye et al. 1999) → structured report on incidence trends. Theorizer generates hypotheses on diabetes-TB interactions from Jeon and Murray (2008), chaining readPaperContent → runPythonAnalysis → theory export. DeepScan verifies HIV risk models from Selwyn et al. (1989) with GRADE checkpoints.
Frequently Asked Questions
What is Global Tuberculosis Epidemiology?
It analyzes worldwide TB incidence, prevalence, transmission, and risks using WHO data and models, as in Dye et al. (1999) estimating 7.96 million cases.
What are key methods used?
Methods include surveillance aggregation (Dye et al., 1999), mathematical modeling for latent burden (Houben and Dodd, 2016), and cohort risk analysis (Selwyn et al., 1989).
What are the most cited papers?
Top papers: Dye et al. (1999, 2960 citations, global burden); Houben and Dodd (2016, 1969 citations, latent TB); Selwyn et al. (1989, 1579 citations, HIV-TB).
What are open problems?
Challenges include underreporting correction, comorbid risk integration (Jeon and Murray, 2008), and real-time transmission modeling amid migration.
Research Tuberculosis Research and Epidemiology with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Global Tuberculosis Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers